A component study of the independent review by Aon found $5,077 in annual savings and 23.5% fewer in

Agreement secured through channel partner Amwell significantly expands Dario's reach through its

Alliance Global Partners analyst Scott Henry initiates coverage on DarioHealth (NASDAQ:DRIO) with

TD Cowen analyst Charles Rhyee maintains DarioHealth (NASDAQ:DRIO) with a Hold and lowers the pri

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst cons

First commercial offering from Dario's collaboration with Beluga Health adds licensed provider e

A member of the Company's Board of Directors participated in the Offering by purchasing 14,430 s

DarioHealth Corp. (NASDAQ:DRIO) (the "Company", "DarioHealth" or "Dario"), a

This opportunity makes Dario's cardiometabolic solution available to the insurer's Administr

The expansion follows success with Dario's behavioral health offering. The health plan's rol

By combining Dario's multi-condition engagement offering with Beluga's physician-led, 50-sta

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.95) per share which beat the analyst cons

Findings highlight the role of continuous behavioral support in improving focus, productivity and da

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.82) per share, which is a 2.12 percent de

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.200 million which beat the analyst consensu

Findings reinforce that engagement data provide clinical signals directly impacting ROIAnalysis furt

As oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectab

Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudge

Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(1.91) per share which beat the analyst cons

New clients span multiple industries and underscore broad increasing demand for Dario's multi-co

The parties have signed a Memorandum of Understanding ("MOU") and expect to conclude a Maste

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday&#39

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announc

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session

DarioHealth Corp. (NASDAQ: DRIO) said Thursday that its board has begun a strategic review followi

 DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in digital he

 DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global

DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global d

Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Amer

Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in

Litchfield Hills analyst Theodore O'Neill initiates coverage on DarioHealth (NASDAQ:DRIO) wit

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.12) per share which met the analyst conse

Strategic partnership expands Dario's employer footprint and has already started contributing to

Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and lowers the price